Patient groups typically form around specific disease areas with an aim of advocating for improved treatments and therapies for patients who fall into those categories—and they’re feeling the ...

When faced with a loved one’s progressive neurodegenerative disease, like Alzheimer’s, or your child’s rare respiratory disease, you question why researchers and resource-backed pharma cannot bring a ...

Advocacy groups for patients with neurologic disorders have become a common feature in the landscape of drug and device development and federal research funding allocation. On Capitol Hill, advocates ...

Pharma is yet to shake its bad reputation among mental health patient groups. As in previous years, the proportion of groups that said the industry has a good or excellent reputation lagged well ...

Please provide your email address to receive an email when new articles are posted on . The world of drug development and commercialization relies heavily on industry stakeholders, as well as the ...

Patient organisations and charities are at risk of aligning their interests with their corporate funders even when this doesn't benefit their members, according to a new study led by the University of ...

A recent Kaufman Hall “Physician Flash Report” for the third quarter of 2025 found that medical group investment dropped in September, a first drop since the COVID-19 pandemic. The median investment ...

A collection of patient advocacy groups is suing to demand the federal government outlaw copay accumulator programs they say inflate healthcare costs. The three groups filed the lawsuit Tuesday in the ...

Andrea Jack, of the Billinge Patient Participation Group, fears if the GP service moves out of the village it will never ...

Polypills formulated to combine three or four antihypertensive medications may be effective treatment strategies for a variety of patient types, three new studies presented at the European Society of ...